Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- COVID-19 (3)
- SARS-CoV-2 (3)
- MicroRNA (miRNA) (2)
- AD continuum (1)
- Adolescents (1)
-
- Alzheimer's disease (AD) (1)
- Alzheimer’s disease (1)
- Angiotensin-converting enzyme 2 receptor (ACE2R) (1)
- Angiotensin-converting enzyme-2 receptor (ACE2R) (1)
- Conjugate vaccine (1)
- Coronavirus (1)
- Creutzfeldt–Jakob disease (CJD) (1)
- Critical care (1)
- Cubital tunnel syndrome (1)
- Cytokine storm (1)
- Disease surveillance (1)
- Drug reinstatement (1)
- Entolimod (1)
- Epidemiology (1)
- Hsa-miRNA-146a-5p (1)
- Hsa-miRNA-15b-5p (1)
- Locomotor activity (1)
- Medication development (1)
- Messenger RNA (mRNA) (1)
- Methamphetamine use disorder (1)
- MiRNA-146a (1)
- MiRNA-155 (1)
- MicroRNA (1)
- Neurological sequelae of COVID-19 (1)
- Omicron variants (1)
Articles 1 - 8 of 8
Full-Text Articles in Medicine and Health Sciences
Omicron Variants Of The Sars-Cov-2: A Potentially Significant Threat In A New Wave Of Infections, Lukasz Szarpak, Michal Pruc, Alla Navolokina, Kavita Batra, Francesco Chirico, Charles De Roquetaillade
Omicron Variants Of The Sars-Cov-2: A Potentially Significant Threat In A New Wave Of Infections, Lukasz Szarpak, Michal Pruc, Alla Navolokina, Kavita Batra, Francesco Chirico, Charles De Roquetaillade
School of Medicine Faculty Publications
From the beginning, the COVID-19 pandemic turned out to be a huge challenge and burden for medical services [1]. Currently, humanity is dealing with a new wave of the virus that has evolved and presents a new challenge, mainly due to its ability to avoid immune surveillance. Indeed, our main line of defense — vaccines — may be compromised. Omicron variants are characterized by an evolutionary force unprecedented so far. Among the several sublines that have already emerged, the BA.5 strain exhibit higher transmissibility and demonstrates a worrisome immune evasion. According to several laboratory investigations, vaccination-induced antibodies are less successful …
Incident Chlamydia Trachomatis Infection In A High School Population, Jacques M. Nsuami, Wato Nsa, Catherine L. Cammarata, David H. Martin, Stephanie N. Taylor
Incident Chlamydia Trachomatis Infection In A High School Population, Jacques M. Nsuami, Wato Nsa, Catherine L. Cammarata, David H. Martin, Stephanie N. Taylor
School of Medicine Faculty Publications
Prospective cohort studies of sexually transmitted infections (STIs) are logistically impractical owing to time and expenses. In schools, students are readily available for school-related follow-ups and monitoring. Capitalizing on the logistics that society already commits to ensure regular attendance of adolescents in school, a school-based STI screening in New Orleans made it possible to naturally observe the occurrence of chlamydia and to determine its incidence among 14–19-year-old adolescents. Among participants screened repeatedly, we calculated incidence rates, cumulative incidence, and incidence times. Male (n = 3820) and female (n = 3501) students were observed for 6251 and 5143 person-years, respectively, during …
Active And Passive Immunization With An Anti-Methamphetamine Vaccine Attenuates The Behavioral And Cardiovascular Effects Of Methamphetamine, Colin N. Haile, Kurt J. Varner, Xia Huijing, Reetakshi Arora, Frank M. Orson, Thomas R. Kosten, Therese A. Kosten
Active And Passive Immunization With An Anti-Methamphetamine Vaccine Attenuates The Behavioral And Cardiovascular Effects Of Methamphetamine, Colin N. Haile, Kurt J. Varner, Xia Huijing, Reetakshi Arora, Frank M. Orson, Thomas R. Kosten, Therese A. Kosten
School of Medicine Faculty Publications
Background: Methamphetamine use disorder (MUD) is a growing health concern with no FDA-approved treatment. The present series of studies build upon our previous work developing an anti-methamphetamine (MA) vaccine for MUD. We determined the effects of a formulation that included tetanus-toxoid (TT) conjugated to succinyl-methamphetamine (TT-SMA) adsorbed onto aluminum hydroxide (alum) in combination with the novel Toll-Like Receptor-5 agonist, entolimod. Methods: Mice were vaccinated (0, 3, 6 weeks) with TT-SMA+alum and various doses of entolimod to determine an optimal dose for enhancing immunogenicity against MA. Functional effects were then assessed using MA-induced locomotor activation in mice. Experiments using passive immunization …
Sars-Cov-2 Invasion And Pathological Links To Prion Disease, Walter J. Lukiw, Vivian R. Jaber, Aileen I. Pogue, Yuhai Zhao
Sars-Cov-2 Invasion And Pathological Links To Prion Disease, Walter J. Lukiw, Vivian R. Jaber, Aileen I. Pogue, Yuhai Zhao
School of Medicine Faculty Publications
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the COVID-19 disease, is a highly infectious and transmissible viral pathogen that continues to impact human health globally. Nearly ~600 million people have been infected with SARS-CoV-2, and about half exhibit some degree of continuing health complication, generically referred to as long COVID. Lingering and often serious neurological problems for patients in the post-COVID-19 recovery period include brain fog, behavioral changes, confusion, delirium, deficits in intellect, cognition and memory issues, loss of balance and coordination, problems with vision, visual processing and hallucinations, encephalopathy, encephalitis, neurovascular or cerebrovascular insufficiency, and/or …
Clinical Characteristics And Implications Of Bradycardia In Covid‐19 Patients Treated With Remdesivir: A Single‐Center Retrospective Cohort Study, Ariyon Schreiber, Justin S. Bauzon, Kavita Batra, Salman Mohammed, Kevin Lee, Nazanin Houshmand, Uyen Pham, Celica Cosme, Kim Inciong, Omar Al‑Taweel, Keaton Nasser, Jibran Rana, Chris Sossou, Ariel Go, Dalia Hawwass, Jimmy Diep, Chowdhury H. Ahsan
Clinical Characteristics And Implications Of Bradycardia In Covid‐19 Patients Treated With Remdesivir: A Single‐Center Retrospective Cohort Study, Ariyon Schreiber, Justin S. Bauzon, Kavita Batra, Salman Mohammed, Kevin Lee, Nazanin Houshmand, Uyen Pham, Celica Cosme, Kim Inciong, Omar Al‑Taweel, Keaton Nasser, Jibran Rana, Chris Sossou, Ariel Go, Dalia Hawwass, Jimmy Diep, Chowdhury H. Ahsan
School of Medicine Faculty Publications
Background and Objectives: Remdesivir is an antiviral drug used to treat coronavirus disease 2019 (COVID-19) with a relatively obscure cardiac efect profle. Previous studies have reported bradycardia associated with remdesivir, but few have examined its clinical characteristics. The objective of this study was to investigate remdesivir associated bradycardia and its associated clinical characteristics and outcomes. Methods: This is a single-institution retrospective study that investigated bradycardia in 600 patients who received remdesivir for treatment of COVID-19. A total of 375 patients were included in the study after screening for other known causes of bradycardia (atrioventricular [AV] nodal blockers). All patients were …
Sars-Cov-2 Neuroinvasion, Inflammatory Neurodegeneration And Alzheimer's Disease, Yuhai Zhao, Walter J. Lukiw
Sars-Cov-2 Neuroinvasion, Inflammatory Neurodegeneration And Alzheimer's Disease, Yuhai Zhao, Walter J. Lukiw
School of Medicine Faculty Publications
No abstract provided.
Microrna, The Innate-Immune System And Sars-Cov-2, James M. Hill, Walter J. Lukiw
Microrna, The Innate-Immune System And Sars-Cov-2, James M. Hill, Walter J. Lukiw
School of Medicine Faculty Publications
The single-stranded viral RNA (ssvRNA) known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 can be effectively inactivated by a number of natural ribonucleic acid-based host cell defenses. One of the most important of these defenses includes the actions of a class of small non-coding RNAs (sncRNAs) known as microRNAs (miRNAs). Via base-pair complementarity miRNAs are capable of specifically targeting ssvRNA sequences such as SARS-CoV-2 promoting its inactivation and neutralization. RNA-sequencing and bioinformatics analysis indicate that multiple naturally-occurring human miRNAs have extensive complementarity to the SARS-CoV-2 ssvRNA genome. Since miRNA abundance, speciation, and complexity vary significantly …
Ulnar Nerve Palsy As Covid-19 Sequelae In 3 Patients, Cristina Terhoeve, Ryan Bliss, Rasheed Ahmad
Ulnar Nerve Palsy As Covid-19 Sequelae In 3 Patients, Cristina Terhoeve, Ryan Bliss, Rasheed Ahmad
School of Medicine Faculty Publications
The pathophysiology and treatment of COVID-19 have been at the forefront of medical research this past year. While great strides have been made in our knowledge of the disease, there is still much that is unknown. More than one-third of patients with COVID-19 present with symptoms involving the nervous system. The reason for this is unclear, although several theories have been postulated. In this case study, we present 3 patients with severe ulnar nerve dysfunction following treatment for COVID-19 in the intensive care unit. We discuss reasons why this may have occurred, the etiology of which is likely multifactorial. We …